These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31911119)

  • 21. Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.
    Ravault S; Friel D; Di Paolo E; Caplanusi A; Gillard P; Povey M; Carryn S
    J Infect Dis; 2019 Sep; 220(9):1462-1468. PubMed ID: 31299077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal antibody response to mumps virus after vaccination and natural infection.
    Tanaka K; Baba K; Okada S; Okuno Y; Yamanishi K; Ueda S; Takahashi M; Yamada A
    Vaccine; 1992; 10(12):824-7. PubMed ID: 1455908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
    Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
    Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a high-throughput assay to measure measles neutralizing antibodies.
    Alvarado-Facundo E; Audet S; Moss WJ; Beeler JA
    PLoS One; 2019; 14(8):e0220780. PubMed ID: 31415584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mumps virus diagnosis and genotyping using a novel single RT-PCR.
    Royuela E; Castellanos A; Sánchez-Herrero C; Sanz JC; De Ory F; Echevarria JE
    J Clin Virol; 2011 Dec; 52(4):359-62. PubMed ID: 21975077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice.
    Vandermeulen C; Verhoye L; Vaidya S; Clement F; Brown KE; Hoppenbrouwers K; Leroux-Roels G
    Immunology; 2010 Sep; 131(1):33-9. PubMed ID: 20586811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
    Vaidya SR; Dvivedi GM; Jadhav SM
    Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological standardization of a test for susceptibility to mumps.
    Shehab ZM; Brunell PA; Cobb E
    J Infect Dis; 1984 May; 149(5):810-2. PubMed ID: 6373967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of humoral immunity to mumps virus.
    Pipkin PA; Afzal MA; Heath AB; Minor PD
    J Virol Methods; 1999 May; 79(2):219-25. PubMed ID: 10381091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples.
    Reid F; Hassan J; Irwin F; Waters A; Hall W; Connell J
    J Clin Virol; 2008 Feb; 41(2):134-7. PubMed ID: 18354822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein.
    Herrera E; Barcenas P; Hernández R; Méndez A; Pérez-Ishiwara G; Barrón B
    Virol J; 2010 Aug; 7():195. PubMed ID: 20727167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Specific humoral immunity after single immunization with mumps vaccine: data of a 3-year follow-up].
    Otrashevskaia AV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2011; 56(3):45-8. PubMed ID: 21786628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype.
    Nöjd J; Tecle T; Samuelsson A; Orvell C
    Vaccine; 2001 Feb; 19(13-14):1727-31. PubMed ID: 11166897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mumps vaccine virus transmission].
    Otrashevskaia EV; Kulak MV; Otrashevskaia AV; Karpov IA; Fisenko EG; Ignat'ev GM
    Vopr Virusol; 2013; 58(6):42-5. PubMed ID: 24772647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.
    Šantak M; Lang-Balija M; Ivancic-Jelecki J; Košutić-Gulija T; Ljubin-Sternak S; Forcic D
    Epidemiol Infect; 2013 Jun; 141(6):1298-309. PubMed ID: 22954346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus.
    Brgles M; Kurtović T; Lang Balija M; Hećimović A; Mušlin T; Halassy B
    J Immunol Methods; 2021 Mar; 490():112957. PubMed ID: 33412172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of school children with live mumps virus vaccine.
    Furesz J; Nagler FP
    Can Med Assoc J; 1970 May; 102(11):1153-5. PubMed ID: 5420994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mumps virus reinfection--clinical findings and serological vagaries.
    Crowley B; Afzal MA
    Commun Dis Public Health; 2002 Dec; 5(4):311-3. PubMed ID: 12564247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.